The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro study
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1538-7836.2010.04106.x/fullpdf
Reference8 articles.
1. Population pharmacokinetics and pharmacodynamics of rivaroxaban - an oral, direct factor Xa inhibitor - in patients undergoing major orthopaedic surgery;Mueck;Clin Pharmacokinet,2008
2. New oral antithrombotics: a need for laboratory monitoring.;Mismetti;J Thromb Haemost,2010
3. Assessment of laboratory assays to measure rivaroxaban - an oral, direct factor Xa inhibitor;Samama;Thromb Haemost,2010
4. Guidelines for thromboplastins and plasmas used to control oral anticoagulant therapy;van den Besselaar;World Health Organ Tech Rep Ser,1999
5. Thromboplastin composition controls the sensitivity of prothrombin time (PT) clotting tests to rivaroxaban, a direct factor Xa inhibitor;Smith;Blood,2007
Cited by 114 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Head-to-head ex vivo comparison of clinically used direct anticoagulant drugs;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-19
2. Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”;Research and Practice in Thrombosis and Haemostasis;2023-05
3. Direct oral anticoagulants (DOACs): From the laboratory point of view;Acta Pharmaceutica;2022-10-18
4. Atrial Fibrillation and Use of Rivaroxaban: Performance of the Prothrombin Time / INR as a Function of Time After Blood Collection;International Journal of Cardiovascular Sciences;2020-10-30
5. Development of an INR for rivaroxaban monitoring using plasma samples from patients;Thrombosis Research;2020-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3